



@article {2289,
	title = {Neuropeptide y expression and function during osteoblast differentiation - Insights from transthyretin knockout mice},
	journal = {FEBS JournalFEBS J.},
	volume = {277},
	year = {2010},
	note = {Cited By (since 1996): 5Export Date: 21 November 2012Source: Scopusdoi: 10.1111/j.1742-4658.2009.07482.xPubMed ID: 19954489Language of Original Document: EnglishCorrespondence Address: Sousa, M. M.; IBMC, Rua Campo Alegre 823, 4150-180 Porto, Portugal; email: msousa@ibmc.up.ptChemicals/CAS: neuropeptide Y, 82785-45-3, 83589-17-7; Amides; DNA Primers; Neuropeptide Y; Prealbumin; RNA, MessengerReferences: McDonald, A.C., Schuijers, J.A., Shen, P.J., Gundlach, A.L., Grills, B.L., Expression of galanin and galanin receptor-1 in normal bone and during fracture repair in the rat (2003) Bone, 33, pp. 788-797;Pacifici, R., Cytokines, estrogen, and postmenopausal osteoporosis - The second decade (1998) Endocrinology, 139, pp. 2659-2661; 
You, L., Temiyasathit, S., Lee, P., Kim, C.H., Tummala, P., Yao, W., Kingery, W., Jacobs, C.R., Osteocytes as mechanosensors in the inhibition of bone resorption due to mechanical loading (2008) Bone, 42, pp. 172-179; 
Chenu, C., Marenzana, M., Sympathetic nervous system and bone remodeling (2005) Joint Bone Spine, 72 (6), pp. 481-483. , DOI 10.1016/j.jbspin.2005.10.007, PII S1297319X05001661; 
Baldock, P.A., Sainsbury, A., Couzens, M., Enriquez, R.F., Thomas, G.P., Gardiner, E.M., Herzog, H., Hypothalamic Y2 receptors regulate bone formation (2002) J Clin Invest, 109, pp. 915-921; 
Baldock, P.A., Allison, S.J., Lundberg, P., Lee, N.J., Slack, K., Lin, E.J., Enriquez, R.F., During, M.J., Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis (2007) J Biol Chem, 282, pp. 19092-19102; 
Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A.F., Beil, F.T., Shen, J., Karsenty, G., Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass (2000) Cell, 100, pp. 197-207; 
Elefteriou, F., Takeda, S., Liu, X., Armstrong, D., Karsenty, G., Monosodium glutamate-sensitive hypothalamic neurons contribute to the control of bone mass (2003) Endocrinology, 144, pp. 3842-3847; 
Elefteriou, F., Neuronal signaling and the regulation of bone remodeling (2005) Cell Mol Life Sci, 62, pp. 2339-2349; 
Bjurholm, A., Kreicbergs, A., Terenius, L., Goldstein, M., Schultzberg, M., Neuropeptide Y-, tyrosine hydroxylase- and vasoactive intestinal polypeptide-immunoreactive nerves in bone and surrounding tissues (1988) J Auton Nerv Syst, 25, pp. 119-125; 
Hill, E.L., Elde, R., Distribution of CGRP-, VIP-, D beta H-, SP-, and NPY-immunoreactive nerves in the periosteum of the rat (1991) Cell Tissue Res, 264, pp. 469-480; 
Tabarowski, Z., Gibson-Berry, K., Felten, S.Y., Noradrenergic and peptidergic innervation of the mouse femur bone marrow (1996) Acta Histochem, 98, pp. 453-457; 
Ahmed, M., Srinivasan, G.R., Theodorsson, E., Bjurholm, A., Kreicbergs, A., Extraction and quantitation of neuropeptides in bone by radioimmunoassay (1994) Regul Pept, 51, pp. 179-188; 
Ericsson, A., Schalling, M., McIntyre, K.R., Lundberg, J.M., Larhammar, D., Seroogy, K., Hokfelt, T., Persson, H., Detection of neuropeptide y and its mRNA in megakaryocytes: Enhanced levels in certain autoimmune mice (1987) Proc Natl Acad Sci USA, 84, pp. 5585-5589; 
Lundberg, P., Allison, S.J., Lee, N.J., Baldock, P.A., Brouard, N., Rost, S., Enriquez, R.F., Simmons, P., Greater bone formation of y2 knockout mice is associated with increased osteoprogenitor numbers and altered y1 receptor expression (2007) J Biol Chem, 282, pp. 19082-19091; 
Stephens, T.W., Basinski, M., Bristow, P.K., Bue-Valleskey, J.M., Burgett, S.G., Craft, L., Hale, J., Kriauciunas, A., The role of neuropeptide y in the antiobesity action of the obese gene product (1995) Nature, 377, pp. 530-532; 
Baldock, P.A., Sainsbury, A., Allison, S., Lin, E.J., Couzens, M., Boey, D., Enriquez, R., Gardiner, E.M., Hypothalamic control of bone formation: Distinct actions of leptin and y2 receptor pathways (2005) J Bone Miner Res, 20, pp. 1851-1857; 
Allison, S., Baldock, P., Enriquez, R., Lin, E., During, M., Gardiner, E., Eisman, J., Herzog, H., Critical interplay between neuropeptide y and sex steroid pathways in bone and adipose tissue homeostasis (2008) J Bone Miner Res, 24, pp. 294-304; 
Nunes, A.F., Saraiva, M.J., Sousa, M.M., Transthyretin knockouts are a new mouse model for increased neuropeptide y (2006) FASEB J, 20, pp. 166-168; 
Mains, R.E., Cullen, E.I., May, V., Eipper, B.A., The role of secretory granules in peptide biosynthesis (1987) Ann NY Acad Sci, 493, pp. 278-291; 
Prigge, S.T., Mains, R.E., Eipper, B.A., Amzel, L.M., New insights into copper monooxygenases and peptide amidation: Structure, mechanism and function (2000) Cell Mol Life Sci, 57, pp. 1236-1259; 
Eipper, B.A., Stoffers, D.A., Mains, R.E., The biosynthesis of neuropeptides: Peptide alpha-amidation (1992) Annu Rev Neurosci, 15, pp. 57-85; 
Teixeira, L., Sousa, D.M., Nunes, A.F., Sousa, M.M., Herzog, H., Lamghari, M., NPY revealed as a critical modulator of osteoblast function in vitro: New insights into the role of Y1 and Y2 receptors (2009) J Cell Biochem, 107, pp. 908-916; 
Amano, S., Arai, M., Goto, S., Togari, A., Inhibitory effect of NPY on isoprenaline-induced osteoclastogenesis in mouse bone marrow cells (2007) Biochim Biophys Acta, 1770, pp. 966-973; 
Baldock, P.A., Allison, S., McDonald, M.M., Sainsbury, A., Enriquez, R.F., Little, D.G., Eisman, J.A., Herzog, H., Hypothalamic regulation of cortical bone mass: Opposing activity of Y2 receptor and leptin pathways (2006) J Bone Miner Res, 21, pp. 1600-1607; 
Saper, C.B., Loewy, A.D., Swanson, L.W., Cowan, W.M., Direct hypothalamo-autonomic connections (1976) Brain Res, 117, pp. 305-312; 
Navia, J.M., Harris, S.S., Vitamin A influence on calcium metabolism and calcification (1980) Ann NY Acad Sci, 355, pp. 45-57; 
Wang, A., Ding, X., Sheng, S., Yao, Z., Retinoic acid inhibits osteogenic differentiation of rat bone marrow stromal cells (2008) Biochem Biophys Res Commun, 375, pp. 435-439; 
Takahashi, T., Kamiya, N., Kawabata, N., Takagi, M., The effect of retinoic acid on a zinc finger transcription factor, AJ18, during differentiation of a rat clonal preosteoblastic cell line, ROB-C20, into osteoblasts (2008) Arch Oral Biol, 53, pp. 87-94; 
Grouzmann, E., Comoy, E., Walker, P., Burnier, M., Bohuon, C., Waeber, B., Brunner, H., Production and characterization of four anti-neuropeptide y monoclonal antibodies (1992) Hybridoma, 11, pp. 409-424; 
Wei, S., Episkopou, V., Piantedosi, R., Maeda, S., Shimada, K., Gottesman, M.E., Blaner, W.S., Studies on the metabolism of retinol and retinol-binding protein in transthyretin-deficient mice produced by homologous recombination (1995) J Biol Chem, 270, pp. 866-870; 
Karga, H., Papapetrou, P.D., Korakovouni, A., Papandroulaki, F., Polymeris, A., Pampouras, G., Bone mineral density in hyperthyroidism (2004) Clin Endocrinol, 61, pp. 466-472; 
Episkopou, V., Maeda, S., Nishiguchi, S., Shimada, K., Gaitanaris, G.A., Gottesman, M.E., Robertson, E.J., Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone (1993) Proc Natl Acad Sci USA, 90, pp. 2375-2379; 
Palha, J.A., Episkopou, V., Maeda, S., Shimada, K., Gottesman, M.E., Saraiva, M.J., Thyroid hormone metabolism in a transthyretin-null mouse strain (1994) J Biol Chem, 269, pp. 33135-33139; 
Palha, J.A., Hays, M.T., Morreale De Escobar, G., Episkopou, V., Gottesman, M.E., Saraiva, M.J., Transthyretin is not essential for thyroxine to reach the brain and other tissues in transthyretin-null mice (1997) Am J Physiol, 272, pp. 485-E493; 
Palha, J.A., Fernandes, R., De Escobar, G.M., Episkopou, V., Gottesman, M., Saraiva, M.J., Transthyretin regulates thyroid hormone levels in the choroid plexus, but not in the brain parenchyma: Study in a transthyretin-null mouse model (2000) Endocrinology, 141, pp. 3267-3272; 
Kingery, W.S., Offley, S.C., Guo, T.Z., Davies, M.F., Clark, J.D., Jacobs, C.R., A substance P receptor (NK1) antagonist enhances the widespread osteoporotic effects of sciatic nerve section (2003) Bone, 33, pp. 927-936; 
Hosaka, H., Nagata, A., Yoshida, T., Shibata, T., Nagao, T., Tanaka, T., Saito, Y., Tatsuno, I., Pancreatic polypeptide is secreted from and controls differentiation through its specific receptors in osteoblastic MC3T3-E1 cells (2008) Peptides, 29, pp. 1390-1395; 
Fleming, C.E., Saraiva, M.J., Sousa, M.M., Transthyretin enhances nerve regeneration (2007) J Neurochem, 103, pp. 831-839; 
Sainsbury, A., Cusin, I., Doyle, P., Rohner-Jeanrenaud, F., Jeanrenaud, B., Intracerebroventricular administration of neuropeptide y to normal rats increases obese gene expression in white adipose tissue (1996) Diabetologia, 39, pp. 353-356; 
Sainsbury, A., Herzog, H., Inhibitory effects of central neuropeptide y on the somatotropic and gonadotropic axes in male rats are independent of adrenal hormones (2001) Peptides, 22, pp. 467-471; 
Marques, F., Sousa, J.C., Oliveira, P., Oliveira, H.C., Palha, J.A., The absence of transthyretin does not impair regulation of lipid and glucose metabolism (2007) Horm Metab Res, 39, pp. 529-533; 
Maniatopoulos, C., Sodek, J., Melcher, A.H., Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats (1988) Cell Tissue Res, 254, pp. 317-330; 
Salingcarnboriboon, R., Tsuji, K., Komori, T., Nakashima, K., Ezura, Y., Noda, M., Runx2 is a target of mechanical unloading to alter osteoblastic activity and bone formation in vivo (2006) Endocrinology, 147, pp. 2296-2305
},
	month = {2010///},
	pages = {263 - 275},
	abstract = {To better understand the role of neuropeptide Y (NPY) in bone homeostasis, as its function in the regulation of bone mass is unclear, we assessed its expression in this tissue. By immunohistochemistry, we demonstrated, both at embryonic stages and in the adult, that NPY is synthesized by osteoblasts, osteocytes, and chondrocytes. Moreover, peptidylglycine α-amidating monooxygenase, the enzyme responsible for NPY activation by amidation, was also expressed in these cell types. Using transthyretin (TTR) KO mice as a model of augmented NPY levels, we showed that this strain has increased NPY content in the bone, further validating the expression of this neuropeptide by bone cells. Moreover, the higher amidated neuropeptide levels in TTR KO mice were related to increased bone mineral density and trabecular volume. Additionally, RT-PCR analysis established that NPY is not only expressed in MC3T3-E1 osteoblastic cells and bone marrow stromal cells (BMSCs), but is also detectable by RIA in BMSCs undergoing osteoblastic differentiation. In agreement with our in vivo observations, in vitro, TTR KO BMSCs differentiated in osteoblasts had increased NPY levels and exhibited enhanced competence in undergoing osteoblastic differentiation. In summary, this work contributes to a better understanding of the role of NPY in the regulation of bone formation by showing that this neuropeptide is expressed in bone cells and that increased amidated neuropeptide content is related to increased bone mass. {\textcopyright} 2009 FEBS.},
	keywords = {3T3 Cells, alpha amidating enzyme, Amidated neuropeptide, amidation, Amides, animal cell, animal tissue, Animals, article, Base Sequence, Bone Density, bone development, bone marrow cell, Bone Marrow Cells, Bone marrow stromal cells, bone mass, cartilage cell, cell differentiation, Cells, Cultured, Chondrocytes, controlled study, developmental stage, DNA Primers, embryo, embryo development, Homeostasis, immunohistochemistry, male, Mice, Mice, Knockout, mouse, Mus, neuropeptide Y, nonhuman, NPY, ossification, osteoblast, Osteoblastic differentiation, Osteoblasts, osteocyte, Osteocytes, peptide synthesis, prealbumin, priority journal, protein expression, protein function, radioimmunoassay, regulatory mechanism, reverse transcription polymerase chain reaction, RNA, Messenger, stroma cell, Stromal Cells, trabecular bone},
	isbn = {1742464X (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-73649127668\&partnerID=40\&md5=c25c87a8e1206fc9d2b878f9611581dd},
	author = {Nunes, A.F. and Liz, M.A. and Franquinho, F. and Teixeira, L. and Sousa, V. and Chenu, C. and Lamghari, M. and Sousa, M.M.}
}
